|
Market Closed -
Bombay S.E.
13:02:28 01/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 596.10 INR | -4.19% |
|
-8.90% | +35.94% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
Company Valuation: Coral Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 350.1 | 1,151 | 912.1 | 817.8 | 1,327 | 2,506 |
| Change | - | 228.83% | -20.78% | -10.34% | 62.25% | 88.85% |
| Enterprise Value (EV) 1 | 398.1 | 1,191 | 729.8 | 517.7 | 1,049 | 2,232 |
| Change | - | 199.05% | -38.7% | -29.07% | 102.64% | 112.77% |
| P/E | 4.91x | 8.49x | 10.1x | 12.7x | 8.4x | 10.4x |
| PBR | 0.3x | 0.84x | 0.58x | 0.53x | 0.75x | 1.25x |
| PEG | - | 0.1x | -0.3x | -0.4x | 0x | 0.2x |
| Capitalization / Revenue | 0.5x | 1.19x | 1.21x | 1.05x | 1.59x | 2.18x |
| EV / Revenue | 0.56x | 1.23x | 0.97x | 0.66x | 1.25x | 1.94x |
| EV / EBITDA | 6.98x | 7.33x | 8.51x | 12.2x | 6.33x | 8.39x |
| EV / EBIT | 10.7x | 8.34x | 11.1x | 25x | 7.18x | 9.07x |
| EV / FCF | -4.65x | -62.2x | -107x | 7.71x | -11.2x | -25.8x |
| FCF Yield | -21.5% | -1.61% | -0.93% | 13% | -8.94% | -3.88% |
| Dividend per Share 2 | - | - | - | - | 2 | 1.5 |
| Rate of return | - | - | - | - | 0.54% | 0.21% |
| EPS 2 | 19.96 | 37.94 | 25.32 | 18.04 | 44.19 | 67.61 |
| Distribution rate | - | - | - | - | 4.53% | 2.22% |
| Net sales 1 | 705.8 | 965.7 | 756.1 | 781.2 | 836.6 | 1,150 |
| EBITDA 1 | 57 | 162.5 | 85.74 | 42.45 | 165.8 | 265.9 |
| EBIT 1 | 37.12 | 142.8 | 65.97 | 20.73 | 146.1 | 246 |
| Net income 1 | 71.3 | 135.5 | 90.46 | 64.45 | 157.9 | 241.6 |
| Net Debt 1 | 48.01 | 39.3 | -182.3 | -300.1 | -277.9 | -273.9 |
| Reference price 2 | 98.00 | 322.25 | 255.30 | 228.90 | 371.40 | 701.40 |
| Nbr of stocks (in thousands) | 3,573 | 3,573 | 3,573 | 3,573 | 3,573 | 3,573 |
| Announcement Date | 8/20/20 A | 9/1/21 A | 9/6/22 A | 7/18/23 A | 9/5/24 A | 9/3/25 A |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 23.36M | |
| 32.93x | 11.96x | 24.23x | 0.6% | 1,031B | |
| 29.57x | - | - | 2.02% | 641B | |
| 32.73x | 7.6x | 15.79x | 2.67% | 453B | |
| 19.66x | 4.67x | 11.58x | 2.83% | 349B | |
| 21.66x | 5.59x | 13.87x | 2.87% | 290B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.19x | 7.03x | 12.5x | 2.35% | 232B | |
| 13.11x | 4.72x | 9.86x | 3.87% | 201B | |
| -44.72x | 6.46x | 25.22x | 2.25% | 181B | |
| Average | 17.00x | 6.54x | 15.66x | 2.39% | 362.98B | |
| Weighted average by Cap. | 23.95x | 7.98x | 17.64x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CORALAB6 Stock
- Valuation Coral Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
